Spots Global Cancer Trial Database for The Intrathecal Morphine for Nephrectomy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: The Intrathecal Morphine for Nephrectomy

Official Title: The Efficacy of Intrathecal Morphine in Patients Undergoing Open Nephrectomy

Study ID: NCT01997788

Conditions

Renal Cell Carcinoma

Interventions

The intrathecal morphine injection

The intravenous patient-controlled analgesia

Demerol on demand

Study Description

Brief Summary: To evaluate the efficacy and the safety of the intrathecal morphine injection in the open nephrectomy.

Detailed Description: The open nephrectomy is the treatment of choice for live donor kidney transplantation and renal cell carcinoma. The incision for the nephrectomy causes severe postoperative pain. A single dose of intrathecal morphine(ITM) has been used for the postoperative pain of prostatectomy, transurethral resection of the prostate and hepatectomy. The effect of ITM for open nephrectomy has not been studied. Therefore, this prospective, randomized study will evaluate the efficacy and safety of a single 50 mcg dose of ITM added to intravenous patient controlled analgesia(IV-PCA), comparing to IV-PCA alone.